{"name":"4-Aminopyridine","slug":"4-aminopyridine","kind":"substance","abbreviations":["4-AP"],"systematic":null,"aliases":["Fampridine","4-Pyridinamine","Dalfampridine","4-Pyridylamine","Avitrol","p-Aminopyridine","Ampyra","γ-Aminopyridine","Phillips 1861","Amino-4 pyridine"],"brands":[],"scraped":true,"has_structure":true,"cid":1727,"classes":[],"families":[],"physical":[{"label":"Molecular mass","value":"94.11 g/mol","copyable":false},{"label":"Appearance","value":"White crystals","copyable":false},{"label":"Odor","value":"Odorless","copyable":false},{"label":"Density","value":"1.2607 at 77.54 °F (USCG, 1999) - Denser than water; will sink","copyable":false},{"label":"Melting point","value":"318 °F (EPA, 1998)","copyable":false},{"label":"Boiling point","value":"524.3 °F at 760 mmHg (EPA, 1998)","copyable":false},{"label":"Decomposition","value":"When heated to decomposition it emits toxic fumes of /nitrogen oxides/.","copyable":false},{"label":"Solubility","value":"74 g/L","copyable":false},{"label":"Predicted LogP","value":"0.3","copyable":false}],"identifiers":[{"label":"Molecular formula","value":"C<sub>5</sub>H<sub>6</sub>N<sub>2</sub>","copyable":true},{"label":"IUPAC name","value":"pyridin-4-amine","copyable":true},{"label":"SMILES","value":"C1=CN=CC=C1N","copyable":true},{"label":"InChI","value":"InChI=1S/C5H6N2/c6-5-1-3-7-4-2-5/h1-4H,(H2,6,7)","copyable":true},{"label":"InChIKey","value":"NUKYPUAOHBNCPY-UHFFFAOYSA-N","copyable":true},{"label":"CAS number","value":"504-24-5","copyable":true},{"label":"UNII","value":"BH3B64OKL9","copyable":true},{"label":"PubChem CID","value":"1727","copyable":true}],"pharmacokinetics":[],"toxicity":[{"kind":"LD50","organisms":[["Dog",[{"kind":"LD50","organism":"Dog","route":"oral","dose":"3.7 mg/kg"}]],["Mouse",[{"kind":"LD50","organism":"Mouse","route":"oral","dose":"50 mg/kg"}]]]}],"dosing":null,"salts":[{"title":"4-Aminopyridine hydrochloride","name":"hydrochloride","slug":"4-aminopyridine_hydrochloride","drawn":true}],"esters":[],"chirality":"achiral","stereo_type":null,"optical_activity":null,"stereoisomers":[],"lipinski":{"passes":true,"violations":0},"reagents":[],"atc":[{"code":"N","description":"Nervous system"},{"code":"N07","description":"Other nervous system drugs"},{"code":"N07X","description":"Other nervous system drugs"},{"code":"N07XX","description":"Other nervous system drugs"},{"code":"N07XX07","description":""},{"code":"N07XX07","description":"Fampridine"}],"mesh":[{"name":"Potassium Channel Blockers","id":"M0379232"}],"actives":[],"prodrugs":[],"codrug":false,"interactions":[],"mechanism":"In MS, axons are progressively demyelinated which exposes potassium channels. As a result, there is a leak of potassium ions which results in the repolarization of cells and a decrease in neuronal excitability. The overall impact is the impairment of neuromuscular transmission as it is harder to trigger an action potential.  Dalfampridine inhibits voltage-gated potassium channels in the CNS to maintain the transmembrane potential and prolong action potential. In other words, dalfampridine works to make sure that the current available is high enough to stimulate conduction in demyelinated axons that are exposed in MS patients. Furthermore, it facilitates neuromuscular and synaptic transmission by relieving conduction blocks in demyelinated axons.","side_effects":{"drug_id":1727,"drug_name":"4-AP","url":"https://sideeffects.embl.de/drugs/1727/pt","atc_codes":[],"side_effects":[{"name":"Urinary tract infection","cui":"C0042029"},{"name":"Insomnia","cui":"C0917801"},{"name":"Asthenia","cui":"C0004093"},{"name":"Dizziness","cui":"C0012833"},{"name":"Headache","cui":"C0018681"},{"name":"Nausea","cui":"C0027497"},{"name":"Back pain","cui":"C0004604"},{"name":"Balance disorder","cui":"C0575090"},{"name":"Nasopharyngitis","cui":"C0027441"},{"name":"Paraesthesia","cui":"C0030554"},{"name":"Multiple sclerosis relapse","cui":"C0856120"},{"name":"Constipation","cui":"C0009806"},{"name":"Dyspepsia","cui":"C0013395"},{"name":"Laryngeal pain","cui":"C0549373"},{"name":"Anaphylactic shock","cui":"C0002792"},{"name":"Angioedema","cui":"C0002994"},{"name":"Anxiety","cui":"C0003467"},{"name":"Mental disorder","cui":"C0004936"},{"name":"Infection","cui":"C0009450"},{"name":"Confusional state","cui":"C0009676"},{"name":"Feeling abnormal","cui":"C1443060"},{"name":"Connective tissue disorder","cui":"C0009782"},{"name":"Dyspnoea","cui":"C0013404"},{"name":"Dermatitis","cui":"C0011603"},{"name":"Rash","cui":"C0015230"},{"name":"Gastrointestinal disorder","cui":"C0017178"},{"name":"Hypersensitivity","cui":"C0020517"},{"name":"Hypotension","cui":"C0020649"},{"name":"Immune system disorder","cui":"C0021053"},{"name":"Mediastinal disorder","cui":"C0025061"},{"name":"Nervous system disorder","cui":"C0027765"},{"name":"Convulsion","cui":"C0036572"},{"name":"Tremor","cui":"C0040822"},{"name":"Urticaria","cui":"C0042109"},{"name":"Angiopathy","cui":"C0042373"},{"name":"Vomiting","cui":"C0042963"},{"name":"Skin disorder","cui":"C0037274"},{"name":"Chest pain","cui":"C0008031"},{"name":"Chest discomfort","cui":"C0235710"},{"name":"Infestation","cui":"C1384353"}],"indications":[{"name":"Multiple sclerosis","cui":"C0026769"},{"name":"Walking disability","cui":"C0311394"}]},"effects":null,"usernotes":[],"erowid":[],"reddit":[],"legal":[],"members":[],"part_of":[],"links":[{"source":"Wikipedia","url":"https://en.wikipedia.org/wiki/4-Aminopyridine"},{"source":"PubChem","url":"https://pubchem.ncbi.nlm.nih.gov/compound/1727"},{"source":"Wikidata","url":"https://www.wikidata.org/wiki/Q372539"},{"source":"DrugBank","url":"https://go.drugbank.com/drugs/DB06637"},{"source":"ChEMBL","url":"https://www.ebi.ac.uk/chembl/explore/compound/CHEMBL284348"},{"source":"ChEBI","url":"https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI%3A34385"},{"source":"Common Chemistry","url":"https://commonchemistry.cas.org/detail?cas_rn=504-24-5"},{"source":"KEGG","url":"https://www.kegg.jp/entry/D04127"},{"source":"EPA DSSTox","url":"https://comptox.epa.gov/dashboard/chemical/details/DTXSID0023870"},{"source":"Effect Index","url":"https://www.effectindex.com/search?q=4%2DAminopyridine"},{"source":"UNII","url":"https://gsrs.ncats.nih.gov/ginas/app/ui/substances/BH3B64OKL9"},{"source":"SIDER","url":"https://sideeffects.embl.de/drugs/1727/pt"}],"references":["National Center for Biotechnology Information. PubChem Compound Summary for CID 1727, 4-Aminopyridine. Accessed November 22, 2026. <a href=https://pubchem.ncbi.nlm.nih.gov/compound/1727>https://pubchem.ncbi.nlm.nih.gov/compound/1727</a>","U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. 4-Aminopyridine. UNII: BH3B64OKL9. Global Substance Registration System. Accessed November 22, 2026. <a href=https://gsrs.ncats.nih.gov/ginas/app/beta/substances/BH3B64OKL9>https://gsrs.ncats.nih.gov/ginas/app/beta/substances/BH3B64OKL9</a>"],"sources":[{"source":"dosing","status":"missing","fetched_at":"2026-11-20 11:00:47","note":"no dosing statistics"},{"source":"drugspro","status":"missing","fetched_at":"2026-11-20 11:00:43","note":"no DrugsPRO reagent data"},{"source":"erowid","status":"missing","fetched_at":"2026-11-20 11:00:43","note":"no Erowid substance of that name"},{"source":"gsrs","status":"ok","fetched_at":"2026-11-20 11:00:44","note":null},{"source":"hmdb","status":"missing","fetched_at":"2026-11-20 11:00:43","note":"no HMDB id"},{"source":"kegg","status":"ok","fetched_at":"2026-11-20 11:00:45","note":null},{"source":"pubchem","status":"ok","fetched_at":"2026-11-20 11:00:43","note":null},{"source":"reddit","status":"missing","fetched_at":"2026-11-20 11:00:43","note":"no r/tripreports posts mention it"},{"source":"sider","status":"ok","fetched_at":"2026-11-20 11:00:43","note":null},{"source":"structure","status":"ok","fetched_at":"2026-11-20 11:00:43","note":null},{"source":"wikipedia","status":"ok","fetched_at":"2026-11-20 11:00:44","note":null}],"description":"4-Aminopyridine is a  substance."}